Genevieve M. Boland
Genevieve M. Boland
Massachusetts General Hospital
Verified email at - Homepage
Cited by
Cited by
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
Adult mesenchymal stem cells and cell-based tissue engineering
RS Tuan, G Boland, R Tuli
Arthritis Res Ther 5 (1), 1-14, 2002
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
Defining T cell states associated with response to checkpoint immunotherapy in melanoma
M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ...
Cell 175 (4), 998-1013. e20, 2018
Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells
GM Boland, G Perkins, DJ Hall, RS Tuan
Journal of cellular biochemistry 93 (6), 1210-1230, 2004
A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade
L Jerby-Arnon, P Shah, MS Cuoco, C Rodman, MJ Su, JC Melms, ...
Cell 175 (4), 984-997. e24, 2018
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
M Sade-Feldman, YJ Jiao, JH Chen, MS Rooney, M Barzily-Rokni, ...
Nature communications 8 (1), 1-11, 2017
CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation
J Deng, ES Wang, RW Jenkins, S Li, R Dries, K Yates, S Chhabra, ...
Cancer discovery 8 (2), 216-233, 2018
Toward minimal residual disease-directed therapy in melanoma
F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ...
Cell 174 (4), 843-855. e19, 2018
Formation and prevention of postoperative abdominal adhesions
GM Boland, RJ Weigel
Journal of Surgical Research 132 (1), 3-12, 2006
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma
N Auslander, G Zhang, JS Lee, DT Frederick, B Miao, T Moll, T Tian, ...
Nature medicine 24 (10), 1545-1549, 2018
Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids
RW Jenkins, AR Aref, PH Lizotte, E Ivanova, S Stinson, CW Zhou, ...
Cancer discovery 8 (2), 196-215, 2018
Cross‐talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation
D Baksh, GM Boland, RS Tuan
Journal of cellular biochemistry 101 (5), 1109-1124, 2007
Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy
MT Chow, AJ Ozga, RL Servis, DT Frederick, JA Lo, DE Fisher, ...
Immunity 50 (6), 1498-1512. e5, 2019
Lineage tracing in humans enabled by mitochondrial mutations and single-cell genomics
LS Ludwig, CA Lareau, JC Ulirsch, E Christian, C Muus, LH Li, K Pelka, ...
Cell 176 (6), 1325-1339. e22, 2019
Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells
L Fischer, G Boland, RS Tuan
Journal of Biological Chemistry 277 (34), 30870-30878, 2002
Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer
GM Boland, GJ Chang, AB Haynes, YJ Chiang, R Chagpar, Y Xing, ...
Cancer 119 (8), 1593-1601, 2013
Granzyme B PET imaging as a predictive biomarker of immunotherapy response
BM Larimer, E Wehrenberg-Klee, F Dubois, A Mehta, T Kalomeris, ...
Cancer Research 77 (9), 2318-2327, 2017
The Human Tumor Atlas Network: charting tumor transitions across space and time at single-cell resolution
O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ...
Cell 181 (2), 236-249, 2020
Wnt signaling during BMP‐2 stimulation of mesenchymal chondrogenesis
L Fischer, G Boland, RS Tuan
Journal of cellular biochemistry 84 (4), 816-831, 2002
The system can't perform the operation now. Try again later.
Articles 1–20